Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A qualitative exploration of barriers and enablers to providing autonomous independent pharmacist prescribing for common clinical conditions in community pharmacy.

Created on 29 Aug 2026

Authors

Lorna Brown, Rachel Bruce, Pamela Macintyre

Published in

The International journal of pharmacy practice. Aug 28, 2026. Epub Aug 28, 2026.

Abstract

In 2020, a national Pharmacy First Plus (PF+) service was introduced in Scotland to enhance healthcare access by enabling community pharmacists with an independent prescribing qualification to diagnose, manage and autonomously prescribe for a wider range of common clinical conditions. Data demonstrated service delivery is variable.
This study aimed to explore the barriers and enablers to delivering PF+ by community pharmacies within National Health Service Greater Glasgow & Clyde (NHSGGC), the largest health board in Scotland.
Between July and December 2023, 12 one-to-one semi-structured interviews with NHSGGC community pharmacist prescribers offering the PF+ service were conducted face to face or virtually. Audio recordings of the interviews were transcribed verbatim and underwent thematic analysis using normalization process theory.
Analysis generated three overarching themes of individual, organizational and contractual factors. Subthemes were pharmacy logistics, clinical skills and training, staffing/skill mix, competing priorities, time challenges and external stakeholder relationships. Many of these were interdependent and had the potential to be a barrier or an enabler to PF+ provision, depending on context.
The barriers and enablers to community pharmacists working as autonomous prescribing pharmacists and delivering a standardized service are multifaceted. With growing opportunities to expand the PF+ service, it is important to address and influence the barriers that currently exist.

PMID:
42664283
Bibliographic data and abstract were imported from PubMed on 29 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement